{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:50:29Z","timestamp":1774432229784,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Noninvasive ventilation (NIV) is the recommended mode of ventilation used in acute respiratory failure secondary to an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Recent data has shown that high-flow nasal cannula (HFNC) treatment can be an alternative for patients with hypercapnic respiratory failure. The purpose of this study is to evaluate HFNC with sequential NIV versus NIV alone as the initial ventilatory strategy in AECOPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This investigator-initiated, unblinded, single center, randomized controlled trial will be conducted in the emergency department, emergency intensive care unit, or respiratory intensive care unit of a tertiary-care urban teaching hospital. A total of 66 patients will be enrolled and randomized into the intervention group (HFNC with sequential NIV) or the control group (NIV group). The primary endpoint will be the mean difference in PaCO\n                      <jats:sub>2<\/jats:sub>\n                      from baseline to 24\u00a0h after randomization. Secondary endpoints include the mean difference in PaCO\n                      <jats:sub>2<\/jats:sub>\n                      from baseline to 6, 12, and 18\u00a0h, as well as the dyspnea score, overall discomfort score, rate of treatment failure, respiratory rate, rate of endotracheal intubation, length of hospital stay, and mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Taking the advantages of both HFNC and NIV on AECOPD patients into account, we designed this clinical trial to investigate the combination of these ventilatory strategies. This trial will help us understand how HFNC with sequential NIV compares to NIV alone in treating AECOPD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ChiCTR2100054809.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06963-w","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:03:03Z","timestamp":1672272183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-flow nasal cannula therapy with sequential noninvasive ventilation versus noninvasive ventilation alone as the initial ventilatory strategy in acute COPD exacerbations: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-6663","authenticated-orcid":false,"given":"Shuai","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Harold","family":"Walline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huadong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"issue":"6","key":"6963_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.pulmoe.2019.08.001","volume":"25","author":"L Pisani","year":"2019","unstructured":"Pisani L, Astuto M, Prediletto I, Longhini F. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology. 2019;25(6):348\u201354.","journal-title":"Pulmonology"},{"key":"6963_CR2","doi-asserted-by":"crossref","unstructured":"Laurent B, Jordi M, Marc W, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333(13):817-22.","DOI":"10.1056\/NEJM199509283331301"},{"issue":"3","key":"6963_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ccm.2020.06.014","volume":"41","author":"A Daher","year":"2020","unstructured":"Daher A, Dreher M. Oxygen therapy and noninvasive ventilation in chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):529\u201345.","journal-title":"Clin Chest Med"},{"issue":"5","key":"6963_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557\u201382.","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"6963_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/resp.13469","volume":"24","author":"V Comellini","year":"2019","unstructured":"Comellini V, Pacilli AMG, Nava S. Benefits of non-invasive ventilation in acute hypercapnic respiratory failure. Respirology. 2019;24(4):308\u201317.","journal-title":"Respirology."},{"key":"6963_CR6","unstructured":"Non-invasive positive pressure ventilation to treat respiratory__failure resulting from exacerbations of chronic obstructive pulmonary disease_ Cochrane systematic review and__meta-analysis."},{"issue":"2","key":"6963_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.medin.2012.09.007","volume":"38","author":"G Rialp Cervera","year":"2014","unstructured":"Rialp Cervera G, del Castillo BA, P\u00e9rez Aizcorreta O, Parra ML. Noninvasive mechanical ventilation in chronic obstructive pulmonary disease and in acute cardiogenic pulmonary edema. Med Intensiva. 2014;38(2):111\u201321.","journal-title":"Med Intensiva"},{"issue":"12","key":"6963_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S2213-2600(18)30388-6","volume":"6","author":"SC Bourke","year":"2018","unstructured":"Bourke SC, Piraino T, Pisani L, Brochard L, Elliott MW. Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implications for practice. Lancet Respir Med. 2018;6(12):935\u201347.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"6963_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/resp.13575","volume":"24","author":"S McKinstry","year":"2019","unstructured":"McKinstry S, Singer J, Baarsma JP, Weatherall M, Beasley R, Fingleton J. Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial. Respirology. 2019;24(11):1081\u20137.","journal-title":"Respirology."},{"issue":"2","key":"6963_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.hrtlng.2020.12.010","volume":"50","author":"PL Yang","year":"2021","unstructured":"Yang PL, Yu JQ, Chen HB. High-flow nasal cannula for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Heart Lung. 2021;50(2):252\u201361.","journal-title":"Heart Lung"},{"issue":"4","key":"6963_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.mcna.2020.02.003","volume":"104","author":"SA Whittaker Brown","year":"2020","unstructured":"Whittaker Brown SA, Braman S. Recent advances in the management of acute exacerbations of chronic obstructive pulmonary disease. Med Clin North Am. 2020;104(4):615\u201330.","journal-title":"Med Clin North Am"},{"issue":"1","key":"6963_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15412555.2020.1715361","volume":"17","author":"I Pantazopoulos","year":"2020","unstructured":"Pantazopoulos I, Daniil Z, Moylan M, et al. Nasal high flow use in COPD patients with hypercapnic respiratory failure: treatment algorithm & review of the literature. COPD. 2020;17(1):101\u201311.","journal-title":"COPD"},{"issue":"6","key":"6963_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/resp.13092","volume":"22","author":"J Braunlich","year":"2017","unstructured":"Braunlich J, Wirtz H. NHF and hypercapnia: how brief can you look? Respirology. 2017;22(6):1049\u201350.","journal-title":"Respirology."},{"issue":"4","key":"6963_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1574887114666190710180540","volume":"14","author":"A Bruni","year":"2019","unstructured":"Bruni A, Garofalo E, Cammarota G, et al. High flow through nasal cannula in stable and exacerbated chronic obstructive pulmonary disease patients. Rev Recent Clin Trials. 2019;14(4):247\u201360.","journal-title":"Rev Recent Clin Trials"},{"key":"6963_CR15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2147\/COPD.S104616","volume":"11","author":"J Br\u00e4unlich","year":"2016","unstructured":"Br\u00e4unlich J, K\u00f6hler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077\u201385.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"6963_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1055\/s-0040-1712101","volume":"41","author":"M Ferrer","year":"2020","unstructured":"Ferrer M, Torres A. Noninvasive ventilation and high-flow nasal therapy administration in chronic obstructive pulmonary disease exacerbations. Semin Respir Crit Care Med. 2020;41(6):786\u201397.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"6963_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s13054-020-03409-0","volume":"24","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani A, Longhini F, Madotto F, et al. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care. 2020;24(1):692.","journal-title":"Crit Care"},{"key":"6963_CR18","doi-asserted-by":"crossref","unstructured":"Viniol C, Vogelmeier CF. Exacerbations of COPD. Eur Respir Rev. 2018;27(147):1-9.","DOI":"10.1183\/16000617.0103-2017"},{"issue":"3","key":"6963_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1183\/09031936.00053814","volume":"45","author":"L Pisani","year":"2015","unstructured":"Pisani L, Mega C, Vaschetto R, et al. Oronasal mask versus helmet in acute hypercapnic respiratory failure. Eur Respir J. 2015;45(3):691\u20139.","journal-title":"Eur Respir J"},{"issue":"6","key":"6963_CR20","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1097\/CCM.0000000000003740","volume":"47","author":"F Longhini","year":"2019","unstructured":"Longhini F, Pisani L, Lungu R, et al. High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial. Crit Care Med. 2019;47(6):e506\u201311.","journal-title":"Crit Care Med"},{"issue":"1","key":"6963_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s13054-020-03214-9","volume":"24","author":"D Tan","year":"2020","unstructured":"Tan D, Walline JH, Ling B, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care. 2020;24(1):489.","journal-title":"Crit Care"},{"issue":"6","key":"6963_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/resp.13050","volume":"22","author":"J Pilcher","year":"2017","unstructured":"Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology. 2017;22(6):1149\u201355.","journal-title":"Respirology."},{"issue":"4","key":"6963_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/crj.13315","volume":"15","author":"A Rezaei","year":"2021","unstructured":"Rezaei A, Fakharian A, Ghorbani F, Idani E, Abedini A, Jamaati H. Comparison of high-flow oxygenation with noninvasive ventilation in COPD exacerbation: a crossover clinical trial. Clin Respir J. 2021;15(4):420\u20139.","journal-title":"Clin Respir J"},{"key":"6963_CR24","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.2147\/COPD.S283020","volume":"15","author":"XY Li","year":"2020","unstructured":"Li XY, Tang X, Wang R, et al. High-flow nasal cannula for chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure: a randomized, controlled trial. Int J Chron Obstruct Pulmon Dis. 2020;15:3051\u201361.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"6963_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000505583","volume":"99","author":"J Elshof","year":"2020","unstructured":"Elshof J, Duiverman ML. Clinical evidence of nasal high-flow therapy in chronic obstructive pulmonary disease patients. Respiration. 2020;99(2):140\u201353.","journal-title":"Respiration"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06963-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:08:42Z","timestamp":1672272522000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06963-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6963"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06963-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1211203\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval will be obtained from the Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College Ethics Committee before the clinical trial started and the patients\u2019 recruitment. The study was registered with the Chinese Clinical Trial Registry (ChiCTR2100054809). Prior to the trial, patients who meet the inclusion criteria will be briefed on the purpose of the study, the intervention, the possible risks, and their rights in the trial. Patients are given 24\u00a0h to consider and will sign an informed consent form if they agree to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"1060"}}